Coronavirus (COVID-19): visiting The Royal Marsden suspended
Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.
As Europe's largest cancer centre, rated 'Outstanding' by the CQC, we have the expertise, technology and facilities to provide the highest standards of personalised care to our private patients.
As a private patient at The Royal Marsden, you will have direct access to some of the most experienced cancer specialists in the world, leading‑edge diagnostic techniques and treatments, and individualised treatment plans based on the latest research.
As a patient at one of the world’s top three cancer centres, you will benefit from our state-of-the-art facilities, the most experienced and respected cancer consultants, and some of the world’s most innovative technology.
When Mr Li found out he might have lung cancer, his daughter encouraged him to come to the UK for treatment.
He’d been offered chemotherapy by his hospital in Beijing, but was keen to get another opinion and see if there was more targeted treatment he could have.
In August 2017 he travelled to The Royal Marsden, a world-leading cancer centre in London to see Professor Sanjay Popat; an internationally renowned expert in the treatment of lung cancer.
He says: "When I saw Professor Sanjay Popat it was promising to hear how positive he was about my options. He was so kind and patient, willing to listen to my every question."
Professor Popat referred him for more tests, which revealed small dots in Mr Li’s lungs. During a biopsy surgeons took out eight tumours, four of which were found to be cancerous.
After three cycles of chemotherapy and 30 radiotherapy sessions, it was suggested that Mr Li considered immunotherapy. This is a hugely promising approach for treating cancer. It explores the interaction between cancer and the immune system to find new systems; it aims to use the body’s own immune system against tumours.
Researchers from The Royal Marsden have been involved in the clinical trials of many of the drugs used in these treatments, pioneering this new option in treatment.
‘Professor Popat said that this drug could be particularly effective for non-small cell lung cancer,’ Mr Li says. ‘He explained it could possibly extend my life for another ten years, which was amazing.
In early March 2019 Mr Li started on immunotherapy, which he initially found quite difficult. Thankfully after a number of sessions his health stabilised, and he continues to have the treatment every two weeks.
He says: ‘My lung cancer has been controlled and now stable. I’m eating well and trying to keep active with daily exercise. I owe my recovery to Professor Popat and The Royal Marsden."
Commenting on The Royal Marsden, he added: 'I found the hospital environment so calming, with even a grand piano in the main foyer, which was often played by patients, families and staff.
‘All the staff were so friendly and accommodating; they got to know me throughout my visit and always had a smile when they greeted me."